KEGG   PATHWAY: mmu05012Help
Entry
mmu05012                    Pathway                                

Name
Parkinson's disease - Mus musculus (mouse)
Description
Parkinson's disease (PD) is a progressive neurodegenerative movement disorder that results primarily from the death of dopaminergic neurons in the substantia nigra. Mutations in alpha-synuclein, UCHL1 (a ubiquitin carboxy-terminal hydrolase L1), parkin, DJ1 (a parkin-associated protein involved with oxidative stress), and PINK1 (a putative serine threonine kinase) are known to cause early-onset PD. These pathogenic mutations are associated with disease through pathogenic pathways that may commonly lead proteasome dysfunction, mitochondrial impairment, and oxidative stress. Point mutations in alpha-synuclein lead to excessive intracellular accumulation and protofibril formation. Decrease in the amount of soluble alpha-synuclein tends to increase free cytoplasmic dopamine and the formation of reactive oxygen species (ROS). Modification of parkin and UCHL1 are associated with the ubiquitin-proteasome system pathway and may increase proteotoxic stress. Mutations in parkin, DJ1, and PINK1 may alter mitochondiral activity, potentially impairing proteasomal function. Environmental toxins such as N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and rotenone can cause mitochondrial dysfunction and oxidative stress.
Class
Human Diseases; Neurodegenerative diseases
BRITE hierarchy
Pathway map
Parkinson's disease
mmu05012

All organismsOrtholog table
Organism
Mus musculus (mouse) [GN:mmu]
Gene
22202  
Uba1y; ubiquitin-activating enzyme, Chr Y [KO:K03178] [EC:6.3.2.19]
22201  
Uba1; ubiquitin-like modifier activating enzyme 1 [KO:K03178] [EC:6.3.2.19]
74153  
Uba7; ubiquitin-like modifier activating enzyme 7 [KO:K10698] [EC:6.3.2.19]
22187  
Ubb; ubiquitin B [KO:K04551]
22195  
Ube2l3; ubiquitin-conjugating enzyme E2L 3 [KO:K04552] [EC:6.3.2.19]
Gm10145; predicted gene 10145 [KO:K04552] [EC:6.3.2.19]
Gm10705; predicted gene 10705 [KO:K04552] [EC:6.3.2.19]
56791  
Ube2l6; ubiquitin-conjugating enzyme E2L 6 [KO:K04553] [EC:6.3.2.19]
140499  
Ube2j2; ubiquitin-conjugating enzyme E2J 2 [KO:K04554] [EC:6.3.2.19]
56228  
Ube2j1; ubiquitin-conjugating enzyme E2J 1 [KO:K10578] [EC:6.3.2.19]
22213  
Ube2g2; ubiquitin-conjugating enzyme E2G 2 [KO:K04555] [EC:6.3.2.19]
67128  
Ube2g1; ubiquitin-conjugating enzyme E2G 1 [KO:K10575] [EC:6.3.2.19]
50873  
Park2; Parkinson disease (autosomal recessive, juvenile) 2, parkin [KO:K04556] [EC:6.3.2.19]
20617  
Snca; synuclein, alpha [KO:K04528]
14763  
Gpr37; G protein-coupled receptor 37 [KO:K04243]
18951  
Sept5; septin 5 [KO:K04557]
67847  
Sncaip; synuclein, alpha interacting protein (synphilin) [KO:K04558]
22223  
Uchl1; ubiquitin carboxy-terminal hydrolase L1 [KO:K05611] [EC:3.4.19.12]
21823  
Th; tyrosine hydroxylase [KO:K00501] [EC:1.14.16.2]
13162  
Slc6a3; solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 [KO:K05036]
110877  
Slc18a1; solute carrier family 18 (vesicular monoamine), member 1 [KO:K08155]
214084  
Slc18a2; solute carrier family 18 (vesicular monoamine), member 2 [KO:K08155]
17716  
ND1; NADH dehydrogenase subunit 1 [KO:K03878] [EC:1.6.5.3]
17717  
ND2; NADH dehydrogenase subunit 2 [KO:K03879] [EC:1.6.5.3]
17718  
ND3; NADH dehydrogenase subunit 3 [KO:K03880] [EC:1.6.5.3]
17719  
ND4; NADH dehydrogenase subunit 4 [KO:K03881] [EC:1.6.5.3]
17720  
ND4L; NADH dehydrogenase subunit 4L [KO:K03882] [EC:1.6.5.3]
17721  
ND5; NADH dehydrogenase subunit 5 [KO:K03883] [EC:1.6.5.3]
17722  
ND6; NADH dehydrogenase subunit 6 [KO:K03884] [EC:1.6.5.3]
17995  
Ndufv1; NADH dehydrogenase (ubiquinone) flavoprotein 1 [KO:K03942] [EC:1.6.99.3 1.6.5.3]
72900  
Ndufv2; NADH dehydrogenase (ubiquinone) flavoprotein 2 [KO:K03943] [EC:1.6.99.3 1.6.5.3]
78330  
Ndufv3; NADH dehydrogenase (ubiquinone) flavoprotein 3 [KO:K03944] [EC:1.6.99.3 1.6.5.3]
54405  
Ndufa1; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1 [KO:K03945] [EC:1.6.99.3 1.6.5.3]
17991  
Ndufa2; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2 [KO:K03946] [EC:1.6.99.3 1.6.5.3]
66091  
Ndufa3; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3 [KO:K03947] [EC:1.6.99.3 1.6.5.3]
17992  
Ndufa4; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4 [KO:K03948] [EC:1.6.99.3 1.6.5.3]
407790  
Ndufa4l2; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 [KO:K03948] [EC:1.6.99.3 1.6.5.3]
68202  
Ndufa5; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5 [KO:K03949] [EC:1.6.99.3 1.6.5.3]
67130  
Ndufa6; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6 (B14) [KO:K03950] [EC:1.6.99.3 1.6.5.3]
66416  
Ndufa7; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7 (B14.5a) [KO:K03951] [EC:1.6.99.3 1.6.5.3]
68375  
Ndufa8; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8 [KO:K03952] [EC:1.6.99.3 1.6.5.3]
66108  
Ndufa9; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9 [KO:K03953] [EC:1.6.99.3 1.6.5.3]
67273  
Ndufa10; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 10 [KO:K03954] [EC:1.6.99.3 1.6.5.3]
70316  
Ndufab1; NADH dehydrogenase (ubiquinone) 1, alpha/beta subcomplex, 1 [KO:K03955] [EC:1.6.99.3 1.6.5.3]
239760  
Gm4943; predicted pseudogene 4943 [KO:K03956] [EC:1.6.5.3]
69875  
Ndufa11; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 11 [KO:K03956] [EC:1.6.5.3]
66414  
Ndufa12; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 12 [KO:K11352] [EC:1.6.99.3 1.6.5.3]
67184  
Ndufa13; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13 [KO:K11353] [EC:1.6.99.3 1.6.5.3]
68198  
Ndufb2; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2 [KO:K03958] [EC:1.6.99.3 1.6.5.3]
66495  
Ndufb3; NADH dehydrogenase (ubiquinone) 1 beta subcomplex 3 [KO:K03959] [EC:1.6.99.3 1.6.5.3]
68194  
Ndufb4; NADH dehydrogenase (ubiquinone) 1 beta subcomplex 4 [KO:K03960] [EC:1.6.99.3 1.6.5.3]
Gm3873; predicted gene 3873 [KO:K03960] [EC:1.6.99.3 1.6.5.3]
Gm3244; predicted pseudogene 3244 [KO:K03960] [EC:1.6.99.3 1.6.5.3]
66046  
Ndufb5; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5 [KO:K03961] [EC:1.6.99.3 1.6.5.3]
230075  
Ndufb6; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6 [KO:K03962] [EC:1.6.99.3 1.6.5.3]
66916  
Ndufb7; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7 [KO:K03963] [EC:1.6.99.3 1.6.5.3]
67264  
Ndufb8; NADH dehydrogenase (ubiquinone) 1 beta subcomplex 8 [KO:K03964] [EC:1.6.99.3 1.6.5.3]
66218  
Ndufb9; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9 [KO:K03965] [EC:1.6.99.3 1.6.5.3]
68342  
Ndufb10; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 10 [KO:K03966] [EC:1.6.99.3 1.6.5.3]
104130  
Ndufb11; NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 11 [KO:K11351] [EC:1.6.99.3 1.6.5.3]
227197  
Ndufs1; NADH dehydrogenase (ubiquinone) Fe-S protein 1 [KO:K03934] [EC:1.6.99.3 1.6.5.3]
226646  
Ndufs2; NADH dehydrogenase (ubiquinone) Fe-S protein 2 [KO:K03935] [EC:1.6.99.3 1.6.5.3]
68349  
Ndufs3; NADH dehydrogenase (ubiquinone) Fe-S protein 3 [KO:K03936] [EC:1.6.99.3 1.6.5.3]
17993  
Ndufs4; NADH dehydrogenase (ubiquinone) Fe-S protein 4 [KO:K03937] [EC:1.6.99.3 1.6.5.3]
595136  
Ndufs5; NADH dehydrogenase (ubiquinone) Fe-S protein 5 [KO:K03938] [EC:1.6.99.3 1.6.5.3]
NADH dehydrogenase [ubiquinone] iron-sulfur protein 5-like; K03938 NADH dehydrogenase (ubiquinone) Fe-S protein 5 [EC:1.6.5.3 1.6.99.3] [KO:K03938] [EC:1.6.99.3 1.6.5.3]
407785  
Ndufs6; NADH dehydrogenase (ubiquinone) Fe-S protein 6 [KO:K03939] [EC:1.6.99.3 1.6.5.3]
623286  
Gm6415; predicted pseudogene 6415 [KO:K03939] [EC:1.6.99.3 1.6.5.3]
631040  
NADH dehydrogenase [ubiquinone] iron-sulfur protein 6; K03939 NADH dehydrogenase (ubiquinone) Fe-S protein 6 [EC:1.6.5.3 1.6.99.3] [KO:K03939] [EC:1.6.99.3 1.6.5.3]
75406  
Ndufs7; NADH dehydrogenase (ubiquinone) Fe-S protein 7 [KO:K03940] [EC:1.6.99.3 1.6.5.3]
225887  
Ndufs8; NADH dehydrogenase (ubiquinone) Fe-S protein 8 [KO:K03941] [EC:1.6.99.3 1.6.5.3]
66377  
Ndufc1; NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1 [KO:K03967] [EC:1.6.99.3 1.6.5.3]
68197  
Ndufc2; NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2 [KO:K03968] [EC:1.6.99.3 1.6.5.3]
635087  
NADH dehydrogenase [ubiquinone] 1 subunit C2-like; K03968 NADH dehydrogenase (ubiquinone) 1 subcomplex unknown 2 [EC:1.6.5.3 1.6.99.3] [KO:K03968] [EC:1.6.99.3 1.6.5.3]
675851  
NADH dehydrogenase [ubiquinone] 1 subunit C2-like; K03968 NADH dehydrogenase (ubiquinone) 1 subcomplex unknown 2 [EC:1.6.5.3 1.6.99.3] [KO:K03968] [EC:1.6.99.3 1.6.5.3]
66945  
Sdha; succinate dehydrogenase complex, subunit A, flavoprotein (Fp) [KO:K00234] [EC:1.3.5.1]
67680  
Sdhb; succinate dehydrogenase complex, subunit B, iron sulfur (Ip) [KO:K00235] [EC:1.3.5.1]
66052  
Sdhc; succinate dehydrogenase complex, subunit C, integral membrane protein [KO:K00236]
66925  
Sdhd; succinate dehydrogenase complex, subunit D, integral membrane protein [KO:K00237]
66694  
Uqcrfs1; ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 [KO:K00411] [EC:1.10.2.2]
17711  
CYTB; cytochrome b [KO:K00412]
66445  
Cyc1; cytochrome c-1 [KO:K00413]
22273  
Uqcrc1; ubiquinol-cytochrome c reductase core protein 1 [KO:K00414]
67003  
Uqcrc2; ubiquinol cytochrome c reductase core protein 2 [KO:K00415]
66576  
Uqcrh; ubiquinol-cytochrome c reductase hinge protein [KO:K00416]
67530  
Uqcrb; ubiquinol-cytochrome c reductase binding protein [KO:K00417]
22272  
Uqcrq; ubiquinol-cytochrome c reductase, complex III subunit VII [KO:K00418]
66152  
Uqcr10; ubiquinol-cytochrome c reductase, complex III subunit X [KO:K00419]
66594  
Uqcr11; ubiquinol-cytochrome c reductase, complex III subunit XI [KO:K00420]
17710  
COX3; cytochrome c oxidase subunit III [KO:K02262]
17708  
COX1; cytochrome c oxidase subunit I [KO:K02256] [EC:1.9.3.1]
17709  
COX2; cytochrome c oxidase subunit II [KO:K02261]
12857  
Cox4i1; cytochrome c oxidase subunit IV isoform 1 [KO:K02263]
84682  
Cox4i2; cytochrome c oxidase subunit IV isoform 2 [KO:K02263]
12858  
Cox5a; cytochrome c oxidase subunit Va [KO:K02264]
12859  
Cox5b; cytochrome c oxidase subunit Vb [KO:K02265]
cytochrome c oxidase subunit 5B; K02265 cytochrome c oxidase subunit 5b [KO:K02265]
12861  
Cox6a1; cytochrome c oxidase subunit VIa polypeptide 1 [KO:K02266]
12862  
Cox6a2; cytochrome c oxidase subunit VIa polypeptide 2 [KO:K02266]
110323  
Cox6b1; cytochrome c oxidase, subunit VIb polypeptide 1 [KO:K02267]
333182  
Cox6b2; cytochrome c oxidase subunit VIb polypeptide 2 [KO:K02267]
12864  
Cox6c; cytochrome c oxidase subunit VIc [KO:K02268]
12866  
Cox7a2; cytochrome c oxidase subunit VIIa 2 [KO:K02270]
12865  
Cox7a1; cytochrome c oxidase subunit VIIa 1 [KO:K02270]
20463  
Cox7a2l; cytochrome c oxidase subunit VIIa polypeptide 2-like [KO:K02270]
66142  
Cox7b; cytochrome c oxidase subunit VIIb [KO:K02271]
78174  
Cox7b2; cytochrome c oxidase subunit VIIb2 [KO:K02271]
12867  
Cox7c; cytochrome c oxidase subunit VIIc [KO:K02272]
cytochrome c oxidase subunit 7C; K02272 cytochrome c oxidase subunit 7c [KO:K02272]
12868  
Cox8a; cytochrome c oxidase subunit VIIIa [KO:K02273]
12869  
Cox8b; cytochrome c oxidase subunit VIIIb [KO:K02273]
75483  
Cox8c; cytochrome c oxidase subunit VIIIc [KO:K02273]
11946  
Atp5a1; ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1 [KO:K02132] [EC:3.6.3.14]
11947  
Atp5b; ATP synthase, H+ transporting mitochondrial F1 complex, beta subunit [KO:K02133] [EC:3.6.3.14]
11949  
Atp5c1; ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1 [KO:K02136] [EC:3.6.3.14]
66043  
Atp5d; ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit [KO:K02134] [EC:3.6.3.14]
67126  
Atp5e; ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit [KO:K02135] [EC:3.6.3.14]
17705  
ATP6; ATP synthase F0 subunit 6 [KO:K02126] [EC:3.6.3.14]
11950  
Atp5f1; ATP synthase, H+ transporting, mitochondrial F0 complex, subunit B1 [KO:K02127] [EC:3.6.3.14]
11951  
Atp5g1; ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c1 (subunit 9) [KO:K02128] [EC:3.6.3.14]
67942  
Atp5g2; ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C2 (subunit 9) [KO:K02128] [EC:3.6.3.14]
228033  
Atp5g3; ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C3 (subunit 9) [KO:K02128] [EC:3.6.3.14]
71679  
Atp5h; ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d [KO:K02138] [EC:3.6.3.14]
28080  
Atp5o; ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit [KO:K02137] [EC:3.6.3.14]
ATP synthase subunit O; K02137 F-type H+-transporting ATPase oligomycin sensitivity conferral protein [EC:3.6.3.14] [KO:K02137] [EC:3.6.3.14]
11957  
Atp5j; ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F [KO:K02131] [EC:3.6.3.14]
17706  
ATP8; ATP synthase F0 subunit 8 [KO:K02125] [EC:3.6.3.14]
66725  
Lrrk2; leucine-rich repeat kinase 2 [KO:K08844] [EC:2.7.11.1]
68943  
Pink1; PTEN induced putative kinase 1 [KO:K05688] [EC:2.7.11.1]
57320  
Park7; Parkinson disease (autosomal recessive, early onset) 7 [KO:K05687]
64704  
Htra2; HtrA serine peptidase 2 [KO:K08669] [EC:3.4.21.108]
22333  
Vdac1; voltage-dependent anion channel 1 [KO:K05862]
22334  
Vdac2; voltage-dependent anion channel 2 [KO:K15040]
22335  
Vdac3; voltage-dependent anion channel 3 [KO:K15041]
11739  
Slc25a4; solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4 [KO:K05863]
11740  
Slc25a5; solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 5 [KO:K05863]
73333  
Slc25a31; solute carrier family 25 (mitochondrial carrier [KO:K05863]
105675  
Ppif; peptidylprolyl isomerase F (cyclophilin F) [KO:K09565] [EC:5.2.1.8]
13063  
Cycs; cytochrome c, somatic [KO:K08738]
13067  
Cyct; cytochrome c, testis [KO:K08738]
11783  
Apaf1; apoptotic peptidase activating factor 1 [KO:K02084]
12371  
Casp9; caspase 9 [KO:K04399] [EC:3.4.22.62]
12367  
Casp3; caspase 3 [KO:K02187] [EC:3.4.22.56]
Compound
C00002  
ATP
C00008  
ADP
C00009  
Orthophosphate
C00013  
Diphosphate
C00020  
AMP
C00027  
Hydrogen peroxide
C00082  
L-Tyrosine
C00355  
3,4-Dihydroxy-L-phenylalanine
C00704  
O2.-
C03758  
Dopamine
C04599  
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
C07593  
Rotenone
C11310  
1-Methyl-4-phenylpyridinium
Reference
  Authors
Thomas B, Beal MF
  Title
Parkinson's disease.
  Journal
Hum Mol Genet 16 Spec No. 2:R183-94 (2007)
Reference
  Authors
Lim KL, Lim TM
  Title
Molecular mechanisms of neurodegeneration in Parkinson's disease: clues from Mendelian syndromes.
  Journal
IUBMB Life 55:315-22 (2003)
Reference
  Authors
Moore DJ, West AB, Dawson VL, Dawson TM
  Title
Molecular pathophysiology of Parkinson's disease.
  Journal
Annu Rev Neurosci 28:57-87 (2005)
Reference
  Authors
Abou-Sleiman PM, Muqit MM, Wood NW
  Title
Expanding insights of mitochondrial dysfunction in Parkinson's disease.
  Journal
Nat Rev Neurosci 7:207-19 (2006)
Reference
  Authors
Mizuno Y, Hattori N, Kubo S, Sato S, Nishioka K, Hatano T, Tomiyama H, Funayama M, Machida Y, Mochizuki H
  Title
Progress in the pathogenesis and genetics of Parkinson's disease.
  Journal
Philos Trans R Soc Lond B Biol Sci 363:2215-27 (2008)
Reference
  Authors
Gandhi S, Wood NW
  Title
Molecular pathogenesis of Parkinson's disease.
  Journal
Hum Mol Genet 14 Spec No. 2:2749-2755 (2005)
Reference
  Authors
Lotharius J, Brundin P
  Title
Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein.
  Journal
Nat Rev Neurosci 3:932-42 (2002)
Reference
  Authors
Eriksen JL, Wszolek Z, Petrucelli L
  Title
Molecular pathogenesis of Parkinson disease.
  Journal
Arch Neurol 62:353-7 (2005)
Reference
  Authors
Sidhu A, Wersinger C, Vernier P
  Title
Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse?
  Journal
FASEB J 18:637-47 (2004)
Reference
  Authors
Sidhu A, Wersinger C, Moussa CE, Vernier P
  Title
The role of alpha-synuclein in both neuroprotection and neurodegeneration.
  Journal
Ann N Y Acad Sci 1035:250-70 (2004)
Reference
  Authors
Dauer W, Przedborski S
  Title
Parkinson's disease: mechanisms and models.
  Journal
Neuron 39:889-909 (2003)
Reference
  Authors
Feany MB
  Title
New genetic insights into Parkinson's disease.
  Journal
N Engl J Med 351:1937-40 (2004)
Reference
  Authors
Beal MF
  Title
Experimental models of Parkinson's disease.
  Journal
Nat Rev Neurosci 2:325-34 (2001)
Reference
  Authors
Corti O, Hampe C, Darios F, Ibanez P, Ruberg M, Brice A
  Title
Parkinson's disease: from causes to mechanisms.
  Journal
C R Biol 328:131-42 (2005)
Reference
  Authors
Vila M, Ramonet D, Perier C
  Title
Mitochondrial alterations in Parkinson's disease: new clues.
  Journal
J Neurochem 107:317-28 (2008)
Reference
  Authors
Vila M, Przedborski S
  Title
Targeting programmed cell death in neurodegenerative diseases.
  Journal
Nat Rev Neurosci 4:365-75 (2003)
KO pathway
 

DBGET integrated database retrieval system